Atrial septal defect and patent foramen ovale closure- complication profile of approved Gore Occluders

Michał Piotrowski1, Julia Izabela Karpierz2, Jakub Batko1

  • 1CAROL-Cardiothoracic Anatomy Research Operative Lab, Department of Cardiovascular Surgery and Transplantology, Institute of Cardiology, Jagiellonian University Medical College, 31-008 Krakow, Poland.

Insights

This study analyzed Gore device complications for patent foramen ovale and atrial septal defects, finding device embolization and arrhythmias were common adverse events. No cardiac erosions were reported, but complication profiles varied by device and size.

Area of Science:

  • Cardiovascular Medicine
  • Medical Device Technology
  • Congenital Heart Disease Research

Background:

  • Patent foramen ovale and atrial septal defects are common congenital heart diseases requiring treatment.
  • Percutaneous or surgical interventions are considered for symptomatic cases.
  • Gore Cardioform and Gore Helex devices are used for closure procedures.

Purpose of the Study:

  • To investigate the post-approval complication profiles of Gore Cardioform and Gore Helex devices.
  • To analyze adverse events reported in the Manufacturer and User Facility Device Experience database.

Main Methods:

  • A retrospective analysis of the Manufacturer and User Facility Device Experience Database.
  • Inclusion of 401 reports detailing complications associated with Gore device closure of atrial septal defects.
  • Categorization of reports by specific Gore device models (Cardioform Septal Occluder, Cardioform ASD Occluder, Helex Septal Occluder).

Main Results:

  • Device problems accounted for 51.4% of complications, primarily device embolization (n=140).
  • Three deaths were reported, two linked to device embolization.
  • Other reported complications included pericardial effusion (54 cases), perforation (14 cases), and postoperative arrhythmias (80 cases), notably atrial fibrillation and heart block.

Conclusions:

  • No cardiac erosions were identified with the use of Gore devices, aligning with previous findings.
  • The complication profiles differed between the investigated Gore devices and their various sizes.
Abstract

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...